110 related articles for article (PubMed ID: 36289976)
1. Virtual Screening for SARS-CoV-2 Main Protease Inhibitory Peptides from the Putative Hydrolyzed Peptidome of Rice Bran.
Harnkit N; Khongsonthi T; Masuwan N; Prasartkul P; Noikaew T; Chumnanpuen P
Antibiotics (Basel); 2022 Sep; 11(10):. PubMed ID: 36289976
[TBL] [Abstract][Full Text] [Related]
2. Computer-Aided Screening for Potential Coronavirus 3-Chymotrypsin-like Protease (3CLpro) Inhibitory Peptides from Putative Hemp Seed Trypsinized Peptidome.
Prasertsuk K; Prongfa K; Suttiwanich P; Harnkit N; Sangkhawasi M; Promta P; Chumnanpuen P
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615263
[TBL] [Abstract][Full Text] [Related]
3. Identification of natural antimicrobial peptides mimetic to inhibit Ca
Asseri AH; Islam MR; Alghamdi RM; Altayb HN
J Bioenerg Biomembr; 2024 Apr; 56(2):125-139. PubMed ID: 38095733
[TBL] [Abstract][Full Text] [Related]
4.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
5. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
Kundu D; Selvaraj C; Singh SK; Dubey VK
J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
[TBL] [Abstract][Full Text] [Related]
6. A Potential Peptide From Soy Cheese Produced Using
Chourasia R; Padhi S; Chiring Phukon L; Abedin MM; Singh SP; Rai AK
Front Mol Biosci; 2020; 7():601753. PubMed ID: 33363209
[TBL] [Abstract][Full Text] [Related]
7. [Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease].
Sulimov AV; Shikhaliev KS; Pyankov OV; Shcherbakov DN; Chirkova VY; Ilin IS; Kutov DC; Tashchilova AS; Krysin MY; Krylskiy DV; Stolpovskaya NV; Volosnikova EA; Belenkaya SV; Sulimov VB
Biomed Khim; 2021 May; 67(3):259-267. PubMed ID: 34142533
[TBL] [Abstract][Full Text] [Related]
8. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
9. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
10. Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.
Huynh T; Wang H; Luan B
Phys Chem Chem Phys; 2020 Nov; 22(43):25335-25343. PubMed ID: 33140777
[TBL] [Abstract][Full Text] [Related]
11. In Silico Identification of Multi-target Anti-SARS-CoV-2 Peptides from Quinoa Seed Proteins.
Wong FC; Ong JH; Kumar DT; Chai TT
Int J Pept Res Ther; 2021; 27(3):1837-1847. PubMed ID: 33867899
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
[TBL] [Abstract][Full Text] [Related]
14. Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its M
Potshangbam AM; Nongdam P; Kumar AK; Rathore RS
Curr Pharm Biotechnol; 2021; 22(15):2054-2070. PubMed ID: 33504301
[TBL] [Abstract][Full Text] [Related]
15. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
16. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
17. Development of a simple and miniaturized sandwich-like fluorescence polarization assay for rapid screening of SARS-CoV-2 main protease inhibitors.
Yan G; Li D; Lin Y; Fu Z; Qi H; Liu X; Zhang J; Si S; Chen Y
Cell Biosci; 2021 Dec; 11(1):199. PubMed ID: 34865653
[TBL] [Abstract][Full Text] [Related]
18. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
19. Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors.
Bhardwaj VK; Singh R; Sharma J; Rajendran V; Purohit R; Kumar S
J Biomol Struct Dyn; 2021 Jul; 39(10):3449-3458. PubMed ID: 32397940
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 Through a Molecular Docking Study.
Mondal M; Sarkar C; Jamaddar S; Khalipha ABR; Islam MT; Mahafzah A; Mubarak MS
Infect Disord Drug Targets; 2021; 21(7):e160921188777. PubMed ID: 33292147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
